Be prepared for a lot more attention on the 340B program in the upcoming Congress, 340B Report Publisher and CEO Ted Slafsky says in his latest column for medication management solutions company Omnicell.
340B was a hot topic in Congress from 2016 to 2018 when Republicans controlled both the House and Senate, Slafsky notes in his Dec. 9 article. But little in the way of 340B legislation besides the bipartisan 340B Protect Act was introduced or debated during the next four years of Democratic control. Starting in January, the GOP will control the House but only by a handful of seats. Democrats will control the Senate 51-49.
Be prepared for a lot more attention on the 340B program in the upcoming Congress, 340B Report Publisher and CEO Ted Slafsky says in his latest column for medication management solutions company Omnicell.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
